United Therapeutics Corporation (UTHR) Options Chain
The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.
United Therapeutics Corporation (UTHR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $24.60B, listed on NASDAQ, employing roughly 1,305 people, carrying a beta of 0.59 to the broader market. United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Led by Martine A. Rothblatt, public since 1999-06-17.
Snapshot as of May 15, 2026.
- Spot Price
- $567.93
- Total OI
- 50.1K
- Total Volume
- 431
- Front Expiration
- 34 days
- Second Expiration
- 63 days
- ATM IV
- 32.7%
- Avg Bid/Ask Spread
- 55.70%
As of May 15, 2026, United Therapeutics Corporation (UTHR) has 50.1K open contracts and 431 contracts traded. The nearest expiration is 34 days out, followed by 63 days. ATM implied volatility is 32.7%. Average bid/ask spread across the chain is 55.70%: wider spreads, size positions conservatively. The options chain aggregates every listed strike and expiration, letting traders evaluate skew, term structure, and liquidity in a single view.
How UTHR options chain Data Feeds Strategy Selection
Strategy selection on United Therapeutics Corporation options does not derive from any single metric in isolation. The options chain view above sits inside a broader read: ATM IV currently sits at 32.7% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options chain data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how the options chain is reported and how to read the data →
UTHR most-active contracts
| Type | Strike | Expiration | Volume | OI | IV | Bid | Ask |
|---|---|---|---|---|---|---|---|
| CALL | $620.00 | Aug 21, 2026 | 0 | 5.7K | 33.1% | $18.30 | $26.00 |
| PUT | $530.00 | Aug 21, 2026 | 1 | 5.7K | 34.9% | $17.70 | $23.70 |
| CALL | $660.00 | Aug 21, 2026 | 2 | 5.7K | 32.6% | $9.10 | $16.00 |
Top 3 contracts from the ORATS-sourced nightly scan; ranked by volume within the broader S&P 500/400/600 + ETF universe.
Frequently asked UTHR options chain questions
- What does the UTHR options chain show right now?
- As of May 15, 2026, United Therapeutics Corporation (UTHR) has 50.1K contracts outstanding and 431 traded today, with ATM IV of 32.7%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.
- What expirations are available for UTHR options?
- The nearest expiration is 34 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.
- How tight are UTHR options bid/ask spreads?
- Average bid/ask spread across the chain is 55.70%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.